Rockefeller Capital Management
ABVX

Rockefeller Capital Management’s Abivax ABVX Stock Holding History

Rockefeller Capital Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.57K Sell
50
-1
-2% -$118 ﹤0.01% 4208
2025
Q4 		$6.88K Buy
+51
New +$5.57K ﹤0.01% 3955

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Rockefeller Capital Management's ABVX Position: Q1 2026 in Review

Rockefeller Capital Management reduced its Abivax (ABVX) stake by 2% in Q1 2026, selling an estimated $118 and leaving 50 shares worth $5.57K. The position accounts for ﹤0.01% of the portfolio, ranked #4208.

Rockefeller Capital Management first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. The position peaked at $6.88K in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Rockefeller Capital Management held 50 shares of Abivax worth $5.57K as of Q1 2026.
  • Rockefeller Capital Management sold 1 Abivax share in Q1 2026, an estimated $118.
  • Abivax made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4208 holding.
  • Rockefeller Capital Management first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • Rockefeller Capital Management's Abivax position peaked at $6.88K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.